Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Many investors were glad to close the books on the first quarter. It's easy to see why.
The S&P 500 dropped 1.2% for the period. Not only that, but the markets turned choppy, posing a big challenge for average retail investors.
But if you have a savvy tech investing guide in your corner, you can do better.
Much better.
Wealth creation better.
Consider that members of my Nova-X Report tech investing service absolutely crushed the market in the first quarter - by 270%. (To find out how to join us at Nova-X and start piling up gains of 104.85%... 121.87%... and 98.09% - and that's just what we've closed out so far in 2018 - take a look here.)
This proves what we say all the time here: The road to wealth is paved by tech.
With that in mind, let's take a look at Nova-X members' four biggest first-quarter winners (remember, this stretch included the market's 10%-plus correction).
And I'll show you what you need to do to start stacking up similar gains of your own...
Tech Weathers the Storm
Now, I can understand if the market has you a bit confused. No doubt about it, there's a lot of uncertainty in the air.
Wall Street continues to worry about a possible trade war with China. And a headline in The Wall Street Journal last Monday about how 10-year Treasuries had hit 3% for the first time in four years also caused a lot of panic selling.
The S&P was down more than 1.3% that day, while the Dow Jones Industrial Average fell more than 1.7%.
Digging under the daily headlines, however, you find tech continues to perform better than those two indexes by very wide margins.
Indeed, the tech-centric Nasdaq Composite Index gained 2.3% over the exact same number of trading days. Then on Thursday, strong earnings in several tech giants, including Facebook Inc. (Nasdaq: FB) and Advanced Micro Devices Inc. (Nasdaq: AMD), helped send markets soaring.
To me, that's solid proof that every investor today needs at least some exposure to high tech and the life sciences. You see, no matter what the "market" does, firms with the most innovative, breakout products are going to keep on transforming the world.
And that will end up pushing those markets higher.
But here's the thing. With a savvy market guide like me in your corner, you can do even better... a lot better.
Just look at the gains we racked up at Nova-X Report in that challenging first quarter, when our average profit was 8.5%.
That may not sound too impressive at first glance - but it means we beat the Nasdaq by 269% - and the Dow and S&P 500 by even more.
And four of our Nova-X winners beat the Nasdaq by 10- to 20-fold.
Take a look...
Nova-X Market Crusher No. 1: Apps Maker Surges 56.6%
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.